王力
西南医科大学附属医院,核医学科,副教授,硕士研究生导师。
教育经历:
2009/10-2012/09 |
日本冈山大学 (Okayama University) |
博士 |
2006/09-2009/07 |
四川大学 (Sichuan University) |
硕士 |
2002/09-2006/07 |
四川大学 (Sichuan University) |
本科 |
工作经历:
2019/10-至今 |
西南医科大学附属医院核医学科 Department of Nuclear Medicien,the Affiliated Hospital of Southwest Medical University |
副教授 |
2017/11-2019/10 |
美国北卡罗来纳大学教堂山分校医学院生物医学影像研究中心 University of North Carolina at Chapel Hill, Biomedical Image Research Center |
博士后 |
2014/12-2017/11 |
西南医科大学药学院 Department of Medicinal Chemisty,School of Pharmacy, Southwest Medical University |
副教授 |
2012/09-2014/12 |
泸州医学院药学院 Department of Medicinal Chemisty,School of Pharmacy, Luzhou Medical College |
讲师 |
研究方向:
1 |
正电子发射断层扫描显像剂及治疗药物的设计、合成标记及活性研究。 |
2 |
小分子酶抑制剂的设计、合成及活性研究。 |
论文专利:
1 |
Enhanced Turnover for the P450 119 Peroxygenase-catalyzed asymmetric epoxidation of styrenes by random mutagenesis, Chemistry - A European Journal, 2018, 24(11): 2741-2749 |
2 |
5-Methyl-N-(8-(5,6,7,8-tetrahydroacridin-9-ylamino) octyl)-5H-indolo[2,3-b] quinolin-11-amine: a highly potent human cholinesterase inhibitor, Medchemcomm, 2017, 8(6): 1307-1317 |
3 |
Total synthesis of chiral falcarindiol analogues using BINOL-promoted akyne addition to adehydes, Molecules, 2016, 21(1): 112-123. |
4 |
Donepezil+propargylamine+8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer’s disease, European Journal of Medicinal Chemistry, 201 4, 80: 543-561 |
5 |
Synthesis and in vitroantiproliferative activity of new 11-aminoalkylamino-substituted 5H-and 6H-indolo[2,3-b]quinolines;structure-activity relationships of neocryptolepines and 6-methyl congeners, Bioorganic & Medicinal Chemistry, 2012, 20(15): 4820-4829 |
6 |
一种合成手性发卡林二醇类似物的方法, 2015-11-13,中国, 201510777519.5. |
7 |
一种BINOL衍生物及其制备方法和应用, 2016-3-10, 中国, 201610137620.9. |
8 |
一种18F-氟标记砜化合物的应用及血池示踪剂的制法, 2020-1-20, 中国, 202010065277.8. |
主持项目: